A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244

A simplified system for generating recombinant adenoviruses

He, T., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,209

Induction of apoptosis in fibroblasts by c-myc protein

Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941

Creation of human tumour cells with defined genetic elements

Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint

Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411

MYC oncogenes and human neoplastic disease

Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,163

Teratocarcinomas and Embryonic Stem Cells: A Practical Approach

Robertson, E. J., & Beddington, R. (1988) · Development · doi:10.1242/dev.102.1.3 · Cited by 1,034

Teratocarcinomas and embryonic stem cells: A practical approach

Krumlauf, R. K. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90286-1 · Cited by 779

THE myc ONCOGENE: ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION

Cole, M. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.002045 · Cited by 699

Function of WW Domains as Phosphoserine- or Phosphothreonine-Binding Modules

Lu, P., Zhou, X. Z., Shen, M., & Lu, K. P. (1999) · Science · doi:10.1126/science.283.5406.1325 · Cited by 688

AKT/PKB signaling: navigating downstream

Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009) · Nature · doi:10.1038/nature07864 · Cited by 1,296

Akt signalling in health and disease

Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,268

The c-Myc target gene network

Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188

ERK signalling: A master regulator of cell behaviour, life and fate

Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185

Transcriptional regulation and transformation by Myc proteins

Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,157

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084

The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

Dhanasekaran, R., Deutzmann, A., Mahauad‐Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00549-2 · Cited by 1,044

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 942

Myc’s broad reach

Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927

LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism

Cartwright, P., McLean, C. A., Sheppard, A. M., Rivett, D., Jones, K., & Dalton, S. (2005) · Development · doi:10.1242/dev.01670 · Cited by 790

ERK implication in cell cycle regulation

Chambard, J., LeFloch, R., Pouysségur, J., & Lenormand, P. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.010 · Cited by 749

PVT1 dependence in cancer with MYC copy-number increase

Tseng, Y., Moriarity, B. S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., Ronning, P., REULAND, B. D., Guenther, K. L., Beadnell, T. C., et al. (2014) · Nature · doi:10.1038/nature13311 · Cited by 743

The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease

Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682

CIP2A inhibits PP2A in human malignancies

Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677

Prolyl cis-trans isomerization as a molecular timer

Lu, K. P., Finn, G., Lee, T. H., & Nicholson, L. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.35 · Cited by 655

Regulation of Raf-1 by direct feedback phosphorylation.

Dougherty, M., Müller, J., Ritt, D. A., Zhou, M., Zhou, X.-Z., Copeland, T., Conrads, T., Veenstra, T., Lu, K., & Morrison, D. (2005) · Molecules and Cells · doi:10.1016/j.molcel.2004.11.055 · Cited by 663

RAF-MEK-ERK pathway in cancer evolution and treatment

Ullah, R., Yin, Q., Snell, A. H., & Wan, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.010 · Cited by 553

Species- and cell type-specific requirements for cellular transformation

Rangarajan, A., Hong, S. J., Gifford, A., & Weinberg, R. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.009 · Cited by 576

Mitochondrial Dysfunction in Cancer

Boland, M. L., Chourasia, A. H., & Macleod, K. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00292 · Cited by 521

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy

Yuan, J., Dong, X., Yap, J., & Hu, J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00949-4 · Cited by 516

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S., Mao, H. C., Chang, J. S., Galietta, A., Uttam, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.015 · Cited by 481

The ubiquitin-specific protease USP28 is required for MYC stability

Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R. L., Bernards, R., Moll, R., Elledge, S. J., & Eilers, M. (2007) · Nature Cell Biology · doi:10.1038/ncb1601 · Cited by 484

MYC degradation

Farrell, A. S., & Sears, R. C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014365 · Cited by 468

Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

Hemann, M. T., Bric, A., Teruya‐Feldstein, J., Herbst, A., Nilsson, J. A., Cordon‐Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452

MYC Deregulation in Primary Human Cancers

Kalkat, M., Melo, J. D., Hickman, K. A., Lourenco, C., Redel, C., Resetca, D., Tamachi, A., Tu, W. B., & Penn, L. Z. (2017) · Genes · doi:10.3390/genes8060151 · Cited by 469

PP2A: the expected tumor suppressor

Janssens, V., Goris, J., & Van Hoof, C. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.004 · Cited by 426

The Life Cycle of C-Myc: From Synthesis to Degradation

Sears, R. C. (2004) · Cell Cycle · doi:10.4161/cc.3.9.1145 · Cited by 415

The Ubiquitin Ligase HectH9 Regulates Transcriptional Activation by Myc and Is Essential for Tumor Cell Proliferation

Adhikary, S., Marinoni, F., Hock, A., Hulleman, E., Popov, N., Beier, R., Bernard, S., Quarto, M., Capra, M. C., Goettig, S., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.016 · Cited by 403

PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)

Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390

MYC and Breast Cancer

Xu, J., Chen, Y., & Olopade, O. I. (2010) · Genes & Cancer · doi:10.1177/1947601910378691 · Cited by 403

Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor

Lonati, E., Brambilla, A., Milani, C., Masserini, M., Palestini, P., & Bulbarelli, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00001 · Cited by 348

Untitled work

(2010) · PubMed Central

Multiple pathways regulated by the tumor suppressor PP2A in transformation

Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344

Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins

Liou, Y., Zhou, X. Z., & Lu, K. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.001 · Cited by 333

Target gene-independent functions of MYC oncoproteins

Baluapuri, A., Wolf, E., & Eilers, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0215-2 · Cited by 310

FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression

Ferber, E. C., Peck, B., Delpuech, O., Bell, G. P., East, P., & Schulze, A. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.179 · Cited by 319

KRAS-Mutant non-small cell lung cancer: From biology to therapy

Ferrer, I., Zugazagoitia, J., Herbertz, S., John, W. J., Paz-Ares, L. G., & Schmid‐Bindert, G. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.013 · Cited by 315

Negative regulation of interferon-regulatory factor 3–dependent innate antiviral response by the prolyl isomerase Pin1

Saitoh, T., Tun-Kyi, A., Ryo, A., Yamamoto, M., Finn, G., Fujita, T., Akira, S., Yamamoto, N., Lu, K. P., & Yamaoka, S. (2006) · Nature Immunology · doi:10.1038/ni1347 · Cited by 303

Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma

Brockmann, M., Poon, E., Berry, T., Carstensen, A., Deubzer, H. E., Rycak, L., Jamin, Y., Thway, K., Robinson, S. P., Roels, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.005 · Cited by 300

Epigenetic responses to environmental change and their evolutionary implications

Turner, B. M. (2009) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0125 · Cited by 310

The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

Liu, K., Zheng, M., Lu, R., Du, J., Zhao, Q., Li, Z., Li, Y., & Zhang, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01304-w · Cited by 297

The alphabet of intrinsic disorder

Theillet, F., Kalmár, L., Tompa, P., Han, K., Selenko, P., Dunker, A. K., Daughdrill, G. W., & Uversky, V. N. (2013) · Intrinsically Disordered Proteins · doi:10.4161/idp.24360 · Cited by 283

The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growthPreprint

Secombe, J., Li, L., Carlos, L. S., & Eisenman, R. N. (2007) · Genes & Development · doi:10.1101/gad.1523007 · Cited by 285

The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target

Zhou, X. Z., & Lu, K. P. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.49 · Cited by 275

Pim kinase-dependent inhibition of c-Myc degradation

Zhang, Y., Wang, Z., Li, X., & Magnuson, N. S. (2008) · Oncogene · doi:10.1038/onc.2008.123 · Cited by 268

PIN1, the cell cycle and cancer

Yeh, E. S., & Means, A. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2107 · Cited by 268

Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression

Hayes, T. K., Neel, N. F., Hu, C., Gautam, P., Chénard, M., Long, B. J., Aziz, M., Kassner, M., Bryant, K. L., Pierobon, M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.011 · Cited by 266

Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis

Saddoughi, S. A., Gencer, S., Peterson, Y. K., Ward, K. E., Mukhopadhyay, A., Oaks, J. J., Bielawski, J., Szulc, Z. M., Thomas, R. J., Selvam, S. P., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201283 · Cited by 272

AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation

Cianfanelli, V., Fuoco, C., Lorente, M., Salazar‐Roa, M., Quondamatteo, F., Gherardini, P. F., Zio, D. D., Nazio, F., Antonioli, M., D’Orazio, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3072 · Cited by 267

Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies

Onyango, I. G., Dennis, J., & Khan, S. M. (2016) · Aging and Disease · doi:10.14336/ad.2015.1007 · Cited by 260

The Ins and Outs of MYC Regulation by Posttranslational Mechanisms

Vervoorts, J., Lüscher‐Firzlaff, J., & Lüscher, B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600017200 · Cited by 259

Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms

Liu, P., Cheng, H.-L. M., Santiago, S., Raeder, M. B., Zhang, F., Isabella, A. J., Yang, J., Semaan, D. J., Chen, C., Fox, E. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2402 · Cited by 258

Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production

Funes, J. M., Quintero, M., Henderson, S. R., Martínez, D., Qureshi, U., Westwood, C., Clements, M. O., Bourboulia, D., Pedley, R. B., Moncada, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700690104 · Cited by 266

Protein phosphatase 2A regulatory subunit B56α associates with c-myc and negatively regulates c-myc accumulation

Arnold, H. K., & Sears, R. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2832-2844.2006 · Cited by 251

MYC in Oncogenesis and as a Target for Cancer Therapies

Albihn, A., Johnsen, J. I., & Arsenian‐Henriksson, M. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07006-5 · Cited by 246

Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Wulf, G. M., Finn, G., Suizu, F., & Lu, K. P. (2005) · Nature Cell Biology · doi:10.1038/ncb0505-435 · Cited by 240

Involvement of PP2A in viral and cellular transformation

Arroyo, J. D., & Hahn, W. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209038 · Cited by 237

Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy

Στρατικόπουλος, Η., Dendy, M., Szabolcs, M. J., Khaykin, A. J., Lefèbvre, C., Zhou, M., & Parsons, R. E. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.006 · Cited by 236

CIP2A Is Associated with Human Breast Cancer Aggressivity

Côme, C., Laine, A., Chanrion, M., Edgren, H., Mattila, E., Liu, X., Jonkers, J., Ivaska, J., Isola, J., Darbon, J.-M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3283 · Cited by 221

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia

Gutierrez, A., Pan, L., Groen, R. W. J., Baleydier, F., Kentsis, A., Marineau, J., Grebliunaite, R., Kozakewich, E., Reed, C., Pflumio, F., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci65093 · Cited by 220

Fuzzy complexes: Specific binding without complete folding

Sharma, R., Ráduly, Z., Miskei, M., & Fuxreiter, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.022 · Cited by 228

Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation

Hydbring, P., Bahram, F., Su, Y., Tronnersjö, S., Högstrand, K., von der Lehr, N., Sharifi, H. R., Lilischkis, R., Hein, N., Wu, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900121106 · Cited by 230

Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer

Maik-Rachline, G., Hacohen-Lev-Ran, A., & Seger, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051194 · Cited by 226

Inhibition of c‐Myc activity by ribosomal protein L11

Dai, M., Arnold, H., Sun, X., Sears, R. C., & Lu, H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601776 · Cited by 221

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

Ahmadi, S. E., Rahimi, S., Zarandi, B., Chegeni, R., & Safa, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01111-4 · Cited by 223

Direct interaction between the inhibitor 2 and ceramide via sphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signaling

Mukhopadhyay, A., Saddoughi, S. A., Song, P., Sultan, I. Y., Ponnusamy, S., Senkal, C. E., Snook, C. F., Arnold, H., Sears, R. C., Hanniui, Y. A., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-120550 · Cited by 217

c-Myc Phosphorylation Is Required for Cellular Response to Oxidative Stress

Benassi, B., Fanciulli, M., Fiorentino, F., Porrello, A., Chiorino, G., Loda, M. F., Zupi, G., & Biroccio, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.009 · Cited by 207

The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase

Sablina, A. A., Chen, W., Arroyo, J. D., Corral, L. G., Hector-Greene, M., Bulmer, S. E., DeCaprio, J. A., & Hahn, W. C. (2007) · Cell · doi:10.1016/j.cell.2007.03.047 · Cited by 207

Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis

Wulf, G. M., Garg, P., Liou, Y., Iglehart, D., & Lu, K. P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600323 · Cited by 201

Prolyl isomerase Pin1 in cancer

Lu, Z., & Hunter, T. R. (2014) · Cell Research · doi:10.1038/cr.2014.109 · Cited by 205

Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer

Shimamura, T., Chen, Z., Soucheray, M., Carretero, J., Kikuchi, E., Tchaicha, J. H., Gao, Y., Cheng, K. A., Cohoon, T. J., Qi, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3904 · Cited by 210

Myc proteins as therapeutic targets

Gustafson, W. C., & Weiss, W. A. (2010) · Oncogene · doi:10.1038/onc.2009.512 · Cited by 204

Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma

Chesler, L., Schlieve, C. R., Goldenberg, D., Kenney, A. M., Kim, G., McMillan, A., Matthay, K. K., Rowitch, D. H., & Weiss, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2769 · Cited by 204

Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation

Deschênes-Simard, X., Gaumont-Leclerc, M.-F., Bourdeau, V., Lessard, F., Moiseeva, O., Forest, V., Igelmann, S., Mallette, F. A., Saba-El-Leil, M. K., Meloche, S., et al. (2013) · Genes & Development · doi:10.1101/gad.203984.112 · Cited by 194

Identification of PP2A Complexes and Pathways Involved in Cell Transformation

Sablina, A. A., Hector, M., Colpaert, N., & Hahn, W. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2855 · Cited by 193

Expression of the AID protein in normal and neoplastic B cells

Pasqualucci, L., Guglielmino, R., Houldsworth, J., Mohr, J., Aoufouchi, S., Polakiewicz, R. D., CHAGANTI, R. S. K., & Dalla‐Favera, R. (2004) · Blood · doi:10.1182/blood-2004-04-1558 · Cited by 193

SCF-mediated protein degradation and cell cycle control

Cambronne, X. A., & Harper, J. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208614 · Cited by 193

Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene

Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 191

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

Janghorban, M., Farrell, A. S., Allen-Petersen, B. L., Pelz, C., Daniel, C. J., Oddo, J., Langer, E. M., Christensen, D. J., & Sears, R. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317630111 · Cited by 186

MYC—Master Regulator of the Cancer Epigenome and Transcriptome

Poole, C. J., & van Riggelen, J. (2017) · Genes · doi:10.3390/genes8050142 · Cited by 180

MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase

Cao, Z., Fan-Minogue, H., Bellovin, D. I., Yevtodiyenko, A., Arzeno, J., Yang, Q., Gambhir, S. S., & Felsher, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3367 · Cited by 181

Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress

Maya‐Mendoza, A., Ostráková, J., Košař, M., Hall, A., Dušková, P., Mistrík, M., Merchut‐Maya, J. M., Hodný, Z., Bártková, J., Christensen, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 179

Molecular Consequences of Silencing Mutant K-ras in Pancreatic Cancer Cells: Justification for K-ras–Directed Therapy

Fleming, J. B., Shen, G.-L., Holloway, S. E., Davis, M., & Brekken, R. A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0206 · Cited by 176

Diverse Functions of Ceramide in Cancer Cell Death and Proliferation

Saddoughi, S. A., & Öğretmen, B. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-394274-6.00002-9 · Cited by 186

β-Catenin-Independent Roles of Wnt/LRP6 Signaling

Acebrón, S. P., & Niehrs, C. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.07.009 · Cited by 182

Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors

Currier, N. V., Solomon, S. E., Demicco, E. G., Chang, D. L. F., Farago, M., Ying, H., Dominguez, I. M., Sonenshein, G. E., Cardiff, R. D., Xiao, Z. J., et al. (2005) · Toxicologic Pathology · doi:10.1080/01926230500352226 · Cited by 173

Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function

Hann, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.08.004 · Cited by 173

Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland

Wang, X., Cunningham, M., Zhang, X., Tokarz, S. A., Laraway, B. J., Troxell, M. L., & Sears, R. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1032 · Cited by 171

Oncogenic regulation of tumor metabolic reprogramming

Tarrado‐Castellarnau, M., de Atauri, P., & Cascante, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10911 · Cited by 165

Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation

Rubio, D., García, S., Paz, M. F., de la Cueva, T., López-Fernández, L. A., Lloyd, A. C., Garcı́a-Castro, J., & Bernad, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001398 · Cited by 166

Pim Family Kinases Enhance Tumor Growth of Prostate Cancer Cells

Chen, W. W., Chan, D. C. F., Donald, C. D., Lilly, M. B., & Kraft, A. S. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0007 · Cited by 161

COP 1 conveys warm temperature information to hypocotyl thermomorphogenesis

Park, Y., Lee, H., Ha, J., Kim, J. Y., & Park, C. (2017) · New Phytologist · doi:10.1111/nph.14581 · Cited by 160

The Mevalonate Pathway, a Metabolic Target in Cancer Therapy

Guerra, B., Recio, C., Aranda-Tavío, H., Guerra-Rodríguez, M., García-Castellano, J. M., & Fernández‐Pérez, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626971 · Cited by 177

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Dubiella, C., Pinch, B. J., Koikawa, K., Zaidman, D., Poon, E., Manz, T. D., Nabet, B., He, S., Resnick, E., Rogel, A., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00786-7 · Cited by 163

Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target

Khanna, A., Pimanda, J. E., & Westermarck, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1994 · Cited by 154

Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination

Fang, X., Zhou, W., Wu, Q., Huang, Z., Shi, Y., Yang, K., Chen, C., Xie, Q., Mack, S. C., Wang, X., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151673 · Cited by 155

Mammalian MYC Proteins and Cancer

Tansey, W. P. (2014) · New Journal of Science · doi:10.1155/2014/757534 · Cited by 166

Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens

Cheng, J., DeCaprio, J. A., Fluck, M. M., & Schaffhausen, B. S. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.03.002 · Cited by 157

PINning down the c-Myc oncoprotein

Dominguez-Sola, D., & Dalla‐Favera, R. (2004) · Nature Cell Biology · doi:10.1038/ncb0404-288 · Cited by 30

Abstract IA10: Post-translational regulation of MYC's oncogenic activity

Sears, R. C., Farrell, A., Wang, X., Liang, J. B., Janghorban, M., Su, Y., Allen-Petersen, B. L., Ohlemeyer, M., & Narla, G. (2015) · Molecular Cancer Research · doi:10.1158/1557-3125.myc15-ia10

Abstract A89: Targeting the MYC activation and degradation pathway for the treatment of pancreatic cancer

Farrell, A. S., Allen-Petersen, B. L., Daniel, C. J., Wang, X., Wang, Z., Christensen, D. J., Sheppard, B. C., & Sears, R. C. (2015) · Cancer Research · doi:10.1158/1538-7445.panca2014-a89

Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels

Ando, S., Ikeda, S., Tanaka, K., Tomabechi, Y., Yamagata, A., Shirouzu, M., Tsunedomi, R., Nagano, H., Tsuji, S., Sato, K., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2509374123

SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62

Wang, W., Liao, P., Shen, M., Chen, T., Chen, Y., Li, Y. C. A. B. W. H., Lin, X., Ge, X., & Wang, P. (2015) · Oncogene · doi:10.1038/onc.2015.106 · Cited by 37